Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Brian Spada Joins UMF|PerfectCLEAN as Regional Sales Manager – Healthcare Markets

Infection prevention expert bolsters UMF|PerfectCLEAN’s growing healthcare team Northbrook, Ill. – March 29, 2023 – Marking the latest expansion of its growing healthcare business, UMF|PerfectCLEAN welcomes Brian Spada as Regional Sales Manager – Healthcare Markets. Brian is an accomplished sales professional who is skilled in client services and results-oriented client management. Most recently with EvaClean, he brings years…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share
Brian Spada Joins UMF|PerfectCLEAN as Regional Sales Manager – Healthcare Markets

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

Infection prevention expert bolsters UMF|PerfectCLEAN’s growing healthcare team

Northbrook, Ill. – March 29, 2023 – Marking the latest expansion of its growing healthcare business, UMF|PerfectCLEAN welcomes Brian Spada as Regional Sales Manager – Healthcare Markets. Brian is an accomplished sales professional who is skilled in client services and results-oriented client management. Most recently with EvaClean, he brings years of healthcare infection prevention expertise.

“We are thrilled to add Brian to our rapidly expanding healthcare team,” said Mark Hodgson, Vice President Sales – Healthcare Markets, UMF|PerfectCLEAN. “His deep knowledge of research-based, science-driven infection prevention solutions comes from years of partnering with some of the country’s leading healthcare facilities. He has helped such organizations achieve industry-leading safety scores and infection rates. Brian’s breadth of experience extends to education, and collegiate and professional sports. We look forward to working with Brian as we enter an exciting new phase of growth.”

Brian has proven abilities in sales and revenue growth, client based expansion, retention, and implementation. While at EvaClean, he co-developed the PurExcellance program, encompassing chemistry adaptation and a specialized clinical training program focused on reducing preventable healthcare associated infections (pHAIs) at healthcare facilities. He trained thousands of hospital staff members during his time there, and regularly exceeded performance goals. Prior to EvaClean, Brian was Regional Sales Manager at Interactive Metronome, where he brought their biometric technology platform to neurologists at leading hospitals and private practices in the Northeast and Caribbean. Before that, he spent more than nine years in sales at Steris, a division of SC Johnson’s DebMed, where he served major hospitals in the Northeast.

“I am thrilled to join UMF|PerfectCLEAN, which is on the cutting edge of infection prevention solutions, development, and innovation,” said Spada. “Committed to sustainability across the board, UMF|PerfectCLEAN is dedicated to ensuring safe environments for patients and healthcare professionals, alike. I am especially enthusiastic to join a company where caregivers and the customers they serve are the top priority.”

“We are thrilled to welcome Brian to our team,” said UMF|PerfectCLEAN CEO George Clarke. “Brian is already contributing to our mission of providing safe environments across all the markets we serve supported by best-in-class products, training, and solutions.”

About UMF Corporation

UMF Corporation is the leader in the research and development of high-performance products, programs and training for the infection prevention and commercial cleaning markets. Through extensive testing, exhaustive analysis and the commitment of significant human and financial resources, new antimicrobial technologies have been merged with innovative product designs that are redefining the future of clean®. LinkedIn.

Media Contact

Michelle Meek

(p) 773-220-3120

michelle@redpillchicago.com

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Tarsus’ $450M Alkeus deal puts phase 3 retina programs on the same integration plan

Tarsus’ $450M Alkeus deal puts phase 3 retina programs on the same integration plan

Tarsus has made a $450 million deal with Alkeus to acquire two assets, including a phase 3 oral Stargardt program and a post-injection antiseptic. The focus now moves to clinical trial operations, chemistry manufacturing and controls, and plans for specialty distribution. These acquisitions aim to expand Tarsus' retina programs.

  • 01Tarsus acquired a phase 3 oral Stargardt asset and a post-injection antiseptic for $450 million.
  • 02The acquisitions focus on enhancing clinical trial operations and chemistry manufacturing controls.
  • 03Plans for future specialty distribution of the acquired assets are in place.

Aug 29, 2026

FDA’s Oct. 19 AI docket forces medtech teams to write tests, not slide decks

FDA’s Oct. 19 AI docket forces medtech teams to write tests, not slide decks

The FDA has released a generative AI discussion paper proposing a shift towards competency-style evaluation and increased postmarket monitoring in the healthcare industry. This move may lead vendors and hospital buyers to prioritize developing robust testing protocols for AI applications. The focus is on ensuring reliable and safe AI implementation in medical technologies.

  • 01The FDA's discussion paper suggests implementing competency-style evaluation for AI in healthcare.
  • 02There is an emphasis on increased postmarket monitoring for AI applications in the medical field.
  • 03Vendors and hospital buyers are encouraged to focus on developing testing protocols rather than presentations.

Aug 29, 2026

SILMO Paris 2026 brings smart glasses and AI into the purchasing cycle

SILMO Paris 2026 brings smart glasses and AI into the purchasing cycle

SILMO Paris 2026 is focusing on integrating smart glasses and AI into the purchasing processes for optical retailers and labs. The event is anticipated to attract around 34,000 visitors and feature 950 exhibitors, indicating significant interest in AI imaging workflows and smart-glass innovations. The agenda highlights a future direction towards advanced technology in optical retail and laboratory settings.

  • 01SILMO Paris 2026 will host nearly 34,000 visitors and 950 exhibitors.
  • 02The event focuses on AI imaging workflows and smart-glass innovations for optical retailers and labs.
  • 03Significant interest is shown in integrating advanced technology within optical retail processes.

Aug 29, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512